Latest hypoglycemia Stories

Chevy Chase, MD -- According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), just one night of short sleep duration can induce insulin resistance, a component of type 2 diabetes."Sleep duration has shortened considerably in western societies in the past decade and simultaneously, there has been an increase in the prevalence of insulin resistance and type 2 diabetes," said Esther Donga, MD of the Leiden...

Racial disparities could result in life-threatening hypoglycemia and increased complicationsResearchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c (HbA1c) response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions. African-American children test significantly higher than Caucasians...

PRINCETON, N.J., May 3 /PRNewswire/ -- Novo Nordisk is launching an online photo contest to help change the way people think about taking insulin. The "Where Have You Flexed" contest is open to patients who use Levemir® FlexPen® (insulin detemir [rDNA origin] injection), NovoLog® FlexPen® (insulin aspart [rDNA origin] injection), and NovoLog® Mix 70/30 FlexPen® (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]). FlexPen® users can...

Mass. General, Boston University researchers run first clinical trial of system using 2 hormonesAn artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston...

MOUNTAIN VIEW, Calif., March 24 /PRNewswire/ -- Based on its recent analysis of the pharmaceuticals and biotechnology market, Frost & Sullivan recognizes MannKind Corporation with the 2010 North America Frost & Sullivan Entrepreneurial Company of the Year Award. The company's growth plan includes the launch of its first marketed product, AFREZZA(TM) (an ultra rapid acting mealtime insulin therapy made using the company's proprietary Technosphere® formulation technology),...

Scientists today described a new ultra-rapid acting mealtime insulin (AFREZZAâ„¢) that is orally inhaled for absorption via the lung. Because the insulin is absorbed so rapidly, AFREZZA's profile closely mimics the normal early insulin response seen in healthy individuals. AFREZZA is awaiting approval by the U. S. Food and Drug Administration (FDA). This presentation took place at the 239th American Chemical Society National Meeting, being held here this week.Andrea Leone-Bay, Ph.D. and...

PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection) is now available in the United States. Victoza is the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. It is indicated in the U.S. as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. Victoza can be used alone (monotherapy) as well as in combination...

Scientists in Cambridge have made a significant step towards developing a so-called "artificial pancreas" system for managing type 1 diabetes in children. The team has developed and successfully tested a new algorithm, providing a stepping stone to home testing for the artificial pancreas.The new study "“ funded by Juvenile Diabetes Research Foundation (JDRF) and published today in The Lancet "“ shows that using an artificial pancreas system overnight can significantly reduce...

-- Research Shows Closed-Loop Systems Control Diabetes, Reduce Dangerous Low Blood Sugar -- LONDON, Feb. 5 /PRNewswire-USNewswire/ -- In a landmark study in children and teenagers with type 1 diabetes, JDRF-funded researchers at the University of Cambridge showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control. Results from the studies are published in the...

LONDON, February 1 /PRNewswire/ -- The latest issue of the journal Diabetic Hypoglycemia ( http://www.hypodiab.com) reviews the role of hypoglycemia in provoking crimes and misdemeanors. Professor Vincent Marks, a leading authority on the forensic aspects of hypoglycemia and its role in criminal behavior, discusses how hypoglycemia-related neuroglycopenia can cause behavioral changes, which can bring people with diabetes into conflict with the law. "Hypoglycemia was recognized as a...